Home›Search›Journal of Thrombosis and Thrombolysis

Journal of Thrombosis and Thrombolysis

Springer · United States

ISSN0929-5305eISSN1573-742X

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.65

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.732

Total Worksi

4,157

Total Citationsi

76,086

2yr Mean Citednessi

1.83

Open Impact Factor alternative

Aims & Scope

Journal of Thrombosis and Thrombolysis is a resource for those involved in the treatment and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. Focuses on pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research, population science and patient care. Publishes original work emphasizing the interface between fundamental scientific principles and clinical investigation and is a platform for translational research, drug development, clinical trials, new drugs and devices, and patient-directed applications. Seeks orignal manuscripts related to cardiovascular disease, laboratory investigation, pharmacogenetics, clinical research, global health, population science, and epidemiology and state-of-the-art reviews and position papers.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published—

FrequencyEight No. A Year, 2009-

StatusActive

Total Publications4,157

Publisher OrgSpringer Science+Business Media

Visit Journal Website

Submission Info

Publishing ModelHybrid

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

⚡ Hybrid journal — subscription model available.

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Springer

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

0929-5305 / 1573-742X

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

225

3.4k

2019

322

10k

2020

269

3.3k

2021

142

1.4k

2022

167

949

2023

140

527

2024

159

242

2025

115

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cardiology and Cardiovascular MedicineQ2

HematologyQ2

Subject Classification

Web of Science Categories

Cardiac & Cardiovascular SystemHematologyPeripheral Vascular Diseases

Scopus Categories

HematologyCardiology and Cardiovascular Medicine

Research Topics (OpenAlex)

Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesAcute Myocardial Infarction ResearchAntiplatelet Therapy and Cardiovascular DiseasesBlood Coagulation and Thrombosis Mechanisms

Frequently asked questions about Journal of Thrombosis and Thrombolysis

Is Journal of Thrombosis and Thrombolysis a predatory journal?

PubScope has no integrity flags on record for Journal of Thrombosis and Thrombolysis: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Journal of Thrombosis and Thrombolysis?

Journal of Thrombosis and Thrombolysis is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.83.

Is Journal of Thrombosis and Thrombolysis indexed in Scopus and Web of Science?

Journal of Thrombosis and Thrombolysis is indexed in Web of Science, Scopus.